Intravenous antiplatelet therapy may improve heart function in cardiogenic shock patients compared to oral medication
Patients who survive cardiogenic shock after a heart attack are among the highest-risk patients and have a significant risk of developing heart failure. Any improvement of heart function should reduce their risk of developing heart failure in the long term.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.